Magnesium sulfate (medical use) solution. In the United Kingdom 4 ml of 20% solution costs the NHS about 10.23 pounds. In the United States a course of medication typically costs less than $25. Magnesium sulfate is the primary treatment and preventative measure in women with eclampsia. It lowers systolic blood pressure while maintaining diastolic blood pressure, thus leaving blood flow to the fetus uncompromised. Magnesium sulphate was once used as a tocolytic, but meta-analyses have failed to support it as an anti-contraction medication. Usage for prolonged periods (more than five to seven days) may result in health problems for the baby. In those at
Magnesium carbonate sulfate) is treated with aqueous sodium carbonate, a precipitate of basic magnesium carbonate—a hydrated complex of magnesium carbonate and magnesium hydroxide—rather than magnesium carbonate itself is formed: High purity industrial routes include a path through magnesium bicarbonate, which can be formed by combining a slurry of magnesium hydroxide and carbon dioxide at high pressure and moderate temperature. The bicarbonate is then vacuum dried, causing it to lose carbon dioxide and a molecule of water: Like many common group 2 metal carbonates, magnesium carbonate reacts with aqueous acids to release carbon dioxide and water: At high temperatures MgCO decomposes to magnesium